Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.
about
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretionvon Willebrand factor: two sides of a coin.Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.Correction of a murine model of von Willebrand disease by gene transfer.Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storageAutosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications.Clearance of von Willebrand factor.Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand diseaseC1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance.von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients.Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.Formation of platelet-binding von Willebrand factor strings on non-endothelial cells.No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand diseaseStorage and secretion of naturally occurring von Willebrand factor A domain variants
P2860
Q24300940-DA31E586-8EE4-4889-A253-3F1AB78D6A65Q33367858-5CEAC84A-2C13-44D3-B7F1-43CDD3BD65D4Q33998293-F7658BE9-9389-45D8-BBB6-BFBEBFA12FF7Q35849850-C76CA5EE-C7DB-405C-AA6E-FE1DD7ABB19EQ35995241-6088DDC3-4D86-4CC5-81AB-46D5F61B5C02Q37175593-4CE1DA2F-540A-4767-86CC-B08FCE1C52E1Q38117738-0B54470D-A3DA-4B97-8A9F-17D6A67B28D1Q39420582-F02878E5-731E-404D-8546-9F46AC2F95F6Q41808379-489BF676-A11B-4256-A40D-CF61A80AC06CQ44327207-0FEA36C8-0C6C-4D89-B395-F0A7767AB97FQ45861284-57D530C2-EEE3-4784-B61B-97840C2A5BE4Q45875800-8989831A-5A49-4ECA-AA3C-3DC3545A2F01Q50491937-D803FEF9-6A44-4082-A043-2D322C02CD5DQ53619865-233D4FF0-2908-4482-8A46-02551A948E52Q58824557-1142135A-8C4D-44EA-AFF4-04336D5A65A5Q58824559-6AF49DEA-A66D-4C2C-8945-DA9B309BE994
P2860
Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dimerization and multimerizati ...... to mutated cysteine residues.
@en
type
label
Dimerization and multimerizati ...... to mutated cysteine residues.
@en
prefLabel
Dimerization and multimerizati ...... to mutated cysteine residues.
@en
P2093
P2860
P1476
Dimerization and multimerizati ...... to mutated cysteine residues.
@en
P2093
Bertina RM
Castaman G
Eikenboom JC
Tjernberg P
P2860
P304
P356
10.1111/J.1538-7836.2003.00435.X
P577
2004-02-01T00:00:00Z